C M van Deuzen, B J A Rijnders, H I Bax, C Rokx, T E M S de Vries-Sluijs, C A M Schurink, J L Nouwen, M de Mendonça-Melo, A A Anas, E van Gorp, L Slobbe, J J van Hellemond, E van Nood
{"title":"21世纪脑弓形体病:荷兰一项回顾性队列研究的长期临床结果","authors":"C M van Deuzen, B J A Rijnders, H I Bax, C Rokx, T E M S de Vries-Sluijs, C A M Schurink, J L Nouwen, M de Mendonça-Melo, A A Anas, E van Gorp, L Slobbe, J J van Hellemond, E van Nood","doi":"10.1097/QAD.0000000000004356","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Cerebral toxoplasmosis is a common opportunistic infection in people with HIV (PWH), associated with high morbidity and mortality. It is unclear how clinical characteristics, treatment response and long-term clinical outcomes in PWH with cerebral toxoplasmosis have changed due to improved treatment of HIV.</p><p><strong>Methods: </strong>This single-centre retrospective observational cohort study of PWH with cerebral toxoplasmosis included patients over almost 25 years.</p><p><strong>Results: </strong>63 eligible patients were identified. Most patients were late presenters presenting with headache and neurological symptoms. Overall survival was 79% over a mean follow up of 15 years. 73% of deaths occurred within the first year after diagnosis. Almost 10% of patients experienced residual impairments.</p><p><strong>Conclusions: </strong>An earlier diagnosis of HIV reduces the incidence of cerebral toxoplasmosis due to timely initiation of cART and anti-Toxoplasma prophylaxis. High index of suspicion by clinicians is vital to timely start anti-Toxoplasma therapy. If treated correctly and timely, overall survival is high.</p>","PeriodicalId":7502,"journal":{"name":"AIDS","volume":" ","pages":""},"PeriodicalIF":3.1000,"publicationDate":"2025-09-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Cerebral toxoplasmosis in the twenty-first century: long-term clinical outcomes in a retrospective cohort study in the Netherlands.\",\"authors\":\"C M van Deuzen, B J A Rijnders, H I Bax, C Rokx, T E M S de Vries-Sluijs, C A M Schurink, J L Nouwen, M de Mendonça-Melo, A A Anas, E van Gorp, L Slobbe, J J van Hellemond, E van Nood\",\"doi\":\"10.1097/QAD.0000000000004356\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Cerebral toxoplasmosis is a common opportunistic infection in people with HIV (PWH), associated with high morbidity and mortality. It is unclear how clinical characteristics, treatment response and long-term clinical outcomes in PWH with cerebral toxoplasmosis have changed due to improved treatment of HIV.</p><p><strong>Methods: </strong>This single-centre retrospective observational cohort study of PWH with cerebral toxoplasmosis included patients over almost 25 years.</p><p><strong>Results: </strong>63 eligible patients were identified. Most patients were late presenters presenting with headache and neurological symptoms. Overall survival was 79% over a mean follow up of 15 years. 73% of deaths occurred within the first year after diagnosis. Almost 10% of patients experienced residual impairments.</p><p><strong>Conclusions: </strong>An earlier diagnosis of HIV reduces the incidence of cerebral toxoplasmosis due to timely initiation of cART and anti-Toxoplasma prophylaxis. High index of suspicion by clinicians is vital to timely start anti-Toxoplasma therapy. If treated correctly and timely, overall survival is high.</p>\",\"PeriodicalId\":7502,\"journal\":{\"name\":\"AIDS\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":3.1000,\"publicationDate\":\"2025-09-23\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"AIDS\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1097/QAD.0000000000004356\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"IMMUNOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"AIDS","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1097/QAD.0000000000004356","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"IMMUNOLOGY","Score":null,"Total":0}
Cerebral toxoplasmosis in the twenty-first century: long-term clinical outcomes in a retrospective cohort study in the Netherlands.
Background: Cerebral toxoplasmosis is a common opportunistic infection in people with HIV (PWH), associated with high morbidity and mortality. It is unclear how clinical characteristics, treatment response and long-term clinical outcomes in PWH with cerebral toxoplasmosis have changed due to improved treatment of HIV.
Methods: This single-centre retrospective observational cohort study of PWH with cerebral toxoplasmosis included patients over almost 25 years.
Results: 63 eligible patients were identified. Most patients were late presenters presenting with headache and neurological symptoms. Overall survival was 79% over a mean follow up of 15 years. 73% of deaths occurred within the first year after diagnosis. Almost 10% of patients experienced residual impairments.
Conclusions: An earlier diagnosis of HIV reduces the incidence of cerebral toxoplasmosis due to timely initiation of cART and anti-Toxoplasma prophylaxis. High index of suspicion by clinicians is vital to timely start anti-Toxoplasma therapy. If treated correctly and timely, overall survival is high.
期刊介绍:
Publishing the very latest ground breaking research on HIV and AIDS. Read by all the top clinicians and researchers, AIDS has the highest impact of all AIDS-related journals. With 18 issues per year, AIDS guarantees the authoritative presentation of significant advances. The Editors, themselves noted international experts who know the demands of your work, are committed to making AIDS the most distinguished and innovative journal in the field. Submitted articles undergo a preliminary review by the editor. Some articles may be returned to authors without further consideration. Those being considered for publication will undergo further assessment and peer-review by the editors and those invited to do so from a reviewer pool.